SPRINT-TB Seminars
We are pleased to invite you to two seminars in October 2016:
Seminar 1Speaker: Prof. Richard K. Haynes, Centre of Excellence for Pharmaceutical Sciences, School of Health Sciences, North-West University,South Africa; Chemistry Department, The Hong Kong University of Science and Technology, Hong Kong
Talk Title: The South African Medical Research Council Flagship Project MALTB REDOX: Development of Oxidant and Redox Drug Combinations for Treatment of TB and Related Diseases When: October 7, 2016, 12.15 pm - 1.15 pm Where: NUS Centre for Translational Medicine (MD6), Seminar Room #01-01A, 14 Medical Drive, Singapore 117599 Click here for a map About the Speaker: Prof.Haynes obtained his Ph.D. degree in organic chemistry in 1970 from the University of Western Australia, and conducted postdoctoral research at the University of Karlsruhe, Germany and Imperial College, London. After appointments at Monash University and University of Sydney, he moved to the Chemistry Department at the Hong Kong University of Science and Technology in 1993 and took up an appointment at the Centre of Excellence for Pharmaceutical Sciences, North-West University, South Africa in 2012. Prof. Haynes served as an external member of the Chemotherapy of Malaria Committee, Tropical Diseases research (TDR), WHO, Geneva (1993-97) and on the Drug Discovery Research Committee, TDR/WHO (1998-2002). He collaborated on the artesunate formulation project with TDR/WHO and participated in the Australian Govt. AusAID Vietnam Malaria Control Project. In collaboration with Bayer AG, Leverkusen (1995-2007), he worked on development of the new artemisinin derivative artemisone. He is author of some 163 publications , 3 book chapters, has 38 patents, and has authored consulting reports for TDR/WHO, government agencies and industry. Please contact us with any enquiries about this event. |
Seminar 2Speaker: Prof. Toshihiro Nukiwa, Executive Director, Japan Anti-Tuberculosis Association (JATA), Japan
Talk Title: TB Control in Japan: Activities and Research of JATA When: October 10, 2016, 12.00 pm - 1.00 pm Where: NUS Dept. of Microbiology, Level 2 Seminar Room, 5 Science Drive 2, Blk MD4A, Singapore 117545 Click here for a map About the Speaker: Prof. Nukiwa, MD, PhD, obtained his medical degree from Tokyo University and performed residence in respiratory medicine. As a visiting associate, he pioneered the mutational analysis on alpha-1 antitrypsin (A1AT) gene and pulmonary emphysema at NHLBI, NIH, USA and identified A1AT Siiyama gene in Japan. He held professorship positions in respiratory medicine in Jutendo University and Tohoku University from 1988. After the discovery of the EGFR driver mutation, he launched the North East Japan Study Group for RCT, and established a new direction of precision medicine using targeting drugs for NSCLC. As a research chair of the national project, he discovered that pirfenidone is a new effective drug for IPF, resulting in the approval of this drug in clinical use. His research has been published in more than 300 papers in distinguished journals. He was the president of Japan Respiratory Society annual meeting in 2007, and the chair of Board Directors, JRS in 2008-10. He is currently the Editor-in-Chief of the official English journal of JRS, Respiratory Investigation. Prof. Nukiwa joined the JATA in 2014 and is now heading the Research Institute of Tuberculosis (RIT), Kiyose, Japan. Please contact us with any enquiries about this event. |
